Contributors to 'Top 10 Emerging Technologies of 2020'
THE STEERING GROUP
Mariette DiChristina, Steering Group chair, is dean and professor of the practice in journalism at the Boston University College of Communication. She was formerly editor in chief of Scientific American and executive vice president, Magazines, for Springer Nature.
Bernard S. Meyerson, Steering Group vice chair, is chief innovation officer emeritus at IBM. He holds awards for work spanning physics, engineering and business.
Anas Faris Al-Faris is president of the King Abdulaziz City for Science and Technology in Riyadh, Saudi Arabia.
Jeff Carbeck, who has built several companies, is CEO of 10EQS.
Rona Chandrawati is a senior lecturer and head of the Nanotechnology for Food and Medicine Laboratory at the University of New South Wales.
P. Murali Doraiswamy, a physician, inventor and professor at the Duke University School of Medicine, is a leading researcher in future technologies and precision medicine and a member of the World Economic Forum's global future councils.
Seth Fletcher is chief features editor of Scientific American.
Javier Garcia Martinez is a professor of inorganic chemistry and director of the Molecular Nanotechnology Laboratory at the University of Alicante.
Katherine Hamilton is director of the Project for Clean Energy and Innovation and chair of 38 North Solutions. She has led several Forum councils.
Rigas Hadzilacos is project lead of the Forum's Preparing for the Future of Work initiative.
Daniel E. Hurtado is an associate professor at the Pontifical Catholic University of Chile. The Forum named him one of the 10 most influential scientists of the future.
Wendy Ju is an assistant professor at the Jacobs Technion–Cornell Institute at Cornell Tech. Ju is a member of the Forum's Global Autonomous and Urban Mobility Council.
Corinna E. Lathan is co-founder and CEO of AnthroTronix and on the board of PTC. Lathan was founding co-chair of the Forum's Global Future Council on Human Enhancement.
Sang Yup Lee, a co-chair of the Forum's Global Future Council on Biotechnology, is Distinguished Professor of chemical and biomolecular engineering at the Korea Advanced Institute of Science and Technology. He holds more than 700 patents.
Geoffrey Ling, a retired U.S. Army colonel, is an expert in technology development and commercial transition. He is a professor of neurology at Johns Hopkins University and the Uniformed Services University of the Health Sciences and a partner of Ling and Associates.
Tammy Ma is program leader for High-Intensity Laser Science at Lawrence Livermore National Laboratory.
Andrew Maynard is director of the Risk Innovation Lab at Arizona State University. His work focuses on the responsible development and use of emerging technologies.
Ruth Morgan is a professor of crime and forensic science at University College London and director of the U.C.L. Center for the Forensic Sciences. She is a member of the Forum's Global Future Council on Virtual and Augmented Reality.
Elizabeth O'Day is CEO and founder of Olaris and co-chair of the Forum's Global Future Council on Biotechnology.
Carlo Ratti is director of the Senseable City Lab at M.I.T. and a founding partner of Carlo Ratti Associati.
Barry Shoop, who retired from the U.S. Army as a brigadier general, is dean of the Albert Nerken School of Engineering at the Cooper Union.
Maria-Elena Torres-Padilla is director of the Institute of Epigenetics and Stem Cells at the Helmholtz Center Munich and a professor of stem cell biology at the Ludwig Maximilian University of Munich.
Sophia M. Velastegui is CTO of artificial intelligence for Dynamics 365 Operation Apps at Microsoft. She is an AI expert for the Forum's Global Future Council on Advanced Manufacturing and Production.
Angela Wu is an assistant professor at the Hong Kong University of Science and Technology and co-founder of Agenovir Corporation, a CRISPR-based therapeutics company.
Xu Xun is CEO of the global genomics organization BGI Group. He is a member of the Forum's Global Future Council on Biotechnology.
GUEST AUTHOR:
Andrew Hessel is president of Humane Genomics.